NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00162721,The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas,https://clinicaltrials.gov/study/NCT00162721,,UNKNOWN,This is a Phase III study about the effects of the addition of polychemotherapy to adjuvant radiotherapy in the treatment of non-metastatic uterine sarcomas.,NO,Uterine Sarcoma,"DRUG: doxorubicin, ifosfamide, cisplatin",Effects of the addition of an adjuvant chemotherapy to adjuvant pelvic radiotherapy on a 3 year event-free survival in the treatment of localized uterine sarcomas,Effects of the addition of an adjuvant chemotherapy to adjuvant pelvic radiotherapy on overall survival|Evaluation of global toxicity of the treatment in each arm,,"Gustave Roussy, Cancer Campus, Grand Paris",,FEMALE,"ADULT, OLDER_ADULT",PHASE3,270,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,SARC-GYN1,2001-09,,,2005-09-13,,2007-08-10,"Institut Gustave Roussy, Villejuif, 94800, France",
